P179 Comparison of the cost per distant disease free year gained of upfront letrozole or anastrozole, or switched exemestane versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women: the UK perspective

✍ Scribed by J. Karnon; S. Kaura; F. di Trapani

• Book ID: 114316092
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 44 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(07)70239-4